Milestone for gene-edited therapy for sickle cell disease
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has…
January 26, 2023 - 3 minutes
CRISPR: A Promising Industry With Many Questions Unanswered
The gene-editing tool CRISPR-Cas9 has taken over the life sciences world since its development in 2012. CRISPR has changed the way biology research is done, simplifying and speeding up the study of diseases and the discovery of drugs, as well as having a huge impact on crop and food development. Among all its possible applications, the fact that CRISPR can be used to tweak the human genome has made it especially promising for previously difficult-to-treat diseases.
But how does CRISPR work? What kind of therapies are being developed? How is the genome-editing market evolving? And how are stakeholders navigating the complex intellectual property around this technology? Find out the answers to these questions and more on this page.
Show More
The Genome Editing Toolbox: ZFNS, TALENS, and CRISPR in Biomedicine
This report covers the industry’s most common genome-editing tools, like CRISPR-Cas9, provides exclusive insights by experts, looks at the market, and addresses future applications and challenges of genome-editing tools.
Go to ReportLatest CRISPR Articles
Aldevron launches type-V CRISPR Nuclease
Aldevron, which develops and manufactures plasmid DNA, RNA and proteins for the biotech industry, has…
January 20, 2023 - 2 minutes
Ensoma acquiring Twelve Bio
Arix Bioscience, a global venture capital company focused on investing in breakthrough biotechnology companies, announced…
January 6, 2023 - 3 minutes
Researchers discover new type of CRISPR gene scissors
Scientists at the Helmholtz Institute Würzburg in Germany, and Benson Hill, Inc. (Missouri) and Utah…
January 5, 2023 - 4 minutes
Navigating running a startup as a Gen Z female founder
By: Alina Su, CEO and founder of NovaXS Biotech Corp The next generation of biotech…
December 14, 2022 - 7 minutes
Actinium Pharmaceuticals and Columbia University to study Actimab-A in AML patients
Actinium Pharmaceuticals, Inc. has entered into a research collaboration with Columbia University to study Actimab-A,…
December 9, 2022 - 4 minutes
New function of CRISPR gene scissors discovered
For several years, the CRISPR/Cas9 gene scissors have been causing a sensation in science and…
November 25, 2022 - 3 minutes
FMRP – the protein behind immunotherapy resistance
Immunotherapy is a cutting-edge approach to treating cancer by turning the patient’s own immune system…
November 21, 2022 - 6 minutes
PACT Pharma reports data from CRISPR cancer study
PACT Pharma, Inc. has reported data from the first clinical study using CRISPR gene editing…
November 11, 2022 - 5 minutes
Companies with exclusive rights to CRISPR diagnostic methods sign agreement
Two companies with sole rights to two CRISPR diagnostic methods in markets outside the U.S.…
November 4, 2022 - 3 minutes
The role of long-read sequencing in validating CRISPR outcomes
Neil Ward, general manager of PacBio EMEA With applications of CRISPR across the spectrum of…
October 20, 2022 - 3 minutes
CRISPR gene editing: a key tool for counteracting climate change
Monika Paulė, CEO and co-founder of the Lithuanian CRISPR developer Caszyme, explains how gene editing…
October 17, 2022 - 6 minutes
